Investor's Business Daily
Edwards Wavers Analysts Debate Its Earnings Miss Amid Hefty TAVR Investments
📊
AI Sentiment
Positive
7/10
Edwards Lifesciences Corporation News
Latest updates and market news for EW
19 news
Feb 6 - Feb 12, 2026
Page 1
MT Newswires
Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Rothschild & Co Redburn Adjusts Edwards Lifesciences PT to $94 From $93, Maintains Buy Rating
📊
AI Sentiment
Positive
6/10
Medical Device Network
Edwards reports strong 2025 despite Q4 EPS miss
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Baird Adjusts Price Target on Edwards Lifesciences to $87 From $90, Maintains Neutral Rating
📊
AI Sentiment
Positive
6/10
MT Newswires
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $95 From $108, Maintains Buy Rating
📊
AI Sentiment
Positive
6/10
MT Newswires
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $87 From $88, Maintains Market Perform Rating
📊
AI Sentiment
Positive
7/10
Barchart
What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock?
📊
AI Sentiment
Positive
6/10
Simply Wall St.
Is Edwards Lifesciences (EW) Share Weakness Creating A Valuation Opportunity?
âž–
AI Sentiment
Neutral
5/10
Simply Wall St.
Estimating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
📊
AI Sentiment
Positive
6/10
24/7 Wall St.
The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk
📈
AI Sentiment
Highly Positive
8/10
Share this news page